Кальций-фосфат

Every time the pH in your mouth drops below 5.5, enamel loses calcium and phosphate ions. This happens after coffee, juice, or any fermentable carbohydrate — which is to say, constantly. Saliva compensates, but only up to a point. Calcium phosphate delivery systems exist to give the remineralization process more raw material to work with.

Three Forms, Three Different Tools

"Calcium phosphate" is not a single ingredient. It describes a family of compounds with different structures, stabilities, and clinical behaviours.

ACP — amorphous calcium phosphate. The least stable and most reactive form. It is the active component in Recaldent technology (CPP-ACP), where casein phosphopeptides from milk protein keep ACP in solution until it reaches the tooth surface. When pH drops, ACP rapidly releases Ca²⁺ and PO₄³⁻ ions, creating the local supersaturation needed to drive hydroxyapatite crystallisation. A 2025 systematic review of 14 studies (Velasco-Ortega et al., PMC12387145) confirmed that CPP-ACP is clinically effective in remineralising white spot lesions in orthodontic patients.

TCP — tricalcium phosphate (Ca₃(PO₄)₂). A more stable form with slower, sustained ion release. Functionalised TCP (fTCP) is formulated together with fluoride in a microencapsulated system that keeps the two components separated until use — preventing premature reaction. A 2021 µCT study (Gittins et al., PMC7590595) demonstrated that a toothpaste containing fTCP and fluoride produced significantly greater remineralisation of artificial enamel subsurface lesions than fluoride alone.

NovaMin — calcium sodium phosphosilicate. Technically a bioactive glass (45S5), not a pure calcium phosphate. But the mechanism is analogous: in contact with saliva, it hydrolyses and releases Ca²⁺, PO₄³⁻, and silicate groups. A layer of hydroxycarbonate apatite forms on the enamel surface. Comparative in vitro data (PMC8525807) places its remineralising effectiveness in the same range as CPP-ACP.

The Mechanism: Ion Supersaturation, Not Surface Coating

Calcium phosphate systems work differently from hydroxyapatite. HAp fills defects physically — it is the same material as enamel and integrates into the crystal lattice. Calcium phosphate systems create ionic supersaturation in saliva and plaque fluid, shifting the thermodynamic equilibrium toward mineral precipitation.

Put simply: the higher the local concentration of Ca²⁺ and PO₄³⁻ near a demineralised area, the more actively new mineral crystallises there. Calcium phosphate systems raise that local concentration precisely when and where it is needed.

"The application of ACP agents during acid challenges provides a buffering effect and creates conditions for remineralization that cannot be achieved by saliva alone." — Llena C et al. (2022), PMC9136455

Synergy with HAp and Fluoride

Calcium phosphate and hydroxyapatite are not duplicates — they address different parts of the same process.

HAp delivers a ready-made structural unit that integrates directly into the enamel lattice. Calcium phosphate raises the ionic activity that governs how fast that lattice grows. Together, they approach mineral recovery from two complementary angles.

With fluoride, the relationship is equally direct. Fluoride converts hydroxyapatite into fluorapatite, which is more acid-resistant. But fluorapatite formation requires calcium and phosphate ions — the very ions that ACP and TCP supply. Lower ion availability means less efficient fluoride uptake.

| Form | Release rate | F compatibility | Key products | |---|---|---|---| | ACP (CPP-ACP) | Fast, pH-triggered | Good | Recaldent, MI Paste | | fTCP | Slow, sustained | High | Clinpro, Duraflor | | NovaMin (bioglass) | Gradual | Moderate | Sensodyne Repair |

Clinical Evidence: What Is Actually Proven

There are no Cochrane-level meta-analyses for calcium phosphate systems as a class. The evidence base is younger than that for fluoride. But the accumulated data support specific clinical applications convincingly.

The best-studied use case is white spot lesions in orthodontic patients. The 2025 systematic review (14 included RCTs and in situ studies) found CPP-ACP significantly more effective than placebo, with fluoride co-application providing additional benefit. For fTCP with fluoride, in vitro data are robust; clinical RCTs are fewer but mechanistically consistent. An in situ study by Cochrane et al. (PMC3967314) found no statistically significant difference between CPP-ACP and standard fluoride control — interpreted as "non-inferior," not as evidence of equivalence.

What This Means in Practice

Calcium phosphate is not a substitute for fluoride or hydroxyapatite. It is an additional mechanism that performs best in combination.

The strongest case for calcium phosphate systems: elevated caries risk, active orthodontic treatment, xerostomia, early-stage white spot lesions. In these situations, the ionic boost produces a measurable clinical outcome.

For a healthy person with routine daily hygiene, calcium phosphate enhances the main formula — it does not replace it.

---

Sources: Burwell AK et al. (2009), Adv Dent Res, DOI:10.1177/0895937409335621 · Cochrane NJ et al. (2014), Int J Oral Sci, PMC3967314 · Gittins V et al. (2021), PMC7590595 · Llena C et al. (2022), PMC9136455 · Velasco-Ortega E et al. (2025), PMC12387145